Many, but not all, outcome studies support exclusion of female plasma from the blood supply

Expert Review of Hematology

Volumn 3, Issue 5, 2010, Pages 551-558

  Stafford Smith, Mark ^a   Lockhart, Evelyn ^a   Bandarenko, Nicholas ^a   Welsby, Ian ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

acute lung injury; cardiac surgery; critical illness; donor gender; plasma; transfusion complications

Indexed keywords

ANTIBODY; CD40 LIGAND; COMPLEMENT COMPONENT C3D; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTOXIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LYSOPHOSPHATIDYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY REACTION; BLOOD DONOR; CARDIOPULMONARY BYPASS; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE ACTIVATION; LITERATURE; LUNG FUNCTION; MORTALITY; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT CARE; PLASMA TRANSFUSION; PRIORITY JOURNAL; RECIPIENT; RED CROSS; REVIEW; SEPSIS; SURVIVAL TIME; THROMBOCYTE; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; ANTIBODIES; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; HUMANS; LUNG; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PLASMA; POLICY; RETROSPECTIVE STUDIES; SEX FACTORS;

EID: 78049416607     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.10.57     Document Type: Review

References (34)

1. Toy P, Popovsky MA, Abraham E et al. Transfusion-related acute lung injury: defnition and review. Crit. Care Med. 33, 721-726 (2005). (Pubitemid 40504378)
2. Kleinman S, Caulfeld T, Chan P et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 44, 1774-1789 (2004). (Pubitemid 39644064)
3. Davis A, Mandal R, Johnson M, Makar R, Stowell C, Dzik S. A touch of TRALI. Transfusion 48, 541-545 (2008). (Pubitemid 351294583)
4. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 25, 573-577 (1985).
5. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus. Med. Rev. 18, 184-188 (2004). (Pubitemid 38962487)
6. Eder AF, Herron R, Strupp A et al. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47, 599-607 (2007). (Pubitemid 46449614)
7. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion 43, 177-184 (2003).
8. Sachs UJ, Hattar K, Weissmann N et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood 107, 1217-1219 (2006). (Pubitemid 43156327)
9. Looney MR, Matthay MA, Looney MR, Matthay MA. Animal models of transfusion-related acute lung injury. Crit. Care Med. 34, S132-S136 (2006). (Pubitemid 43670480)
10. Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus. Med. Rev. 23, 266-283 (2009).
11. Looney MR, Nguyen JX, Hu Y, Van Ziffe JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J. Clin. Invest. 119, 3450-3461 (2009).
12. Triulzi DJ, Kleinman S, Kakaiya RM et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 49, 1825-1835 (2009).
13. Greinacher A, Wesche J, Hammer E et al. Characterization of the human neutrophil alloantigen-3a. Nat. Med. 16, 45-48 (2010).
14. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 44, 1683-1688 (2004). (Pubitemid 39644050)
15. Krochmal JD, Dwyre DM, Swanson KM, Raife TJ, Schlueter AJ. Recurrent transfusion-related acute lung injury after a two-year interval. Transfus. Med. 17, 192-196 (2007). (Pubitemid 46897121)
16. Silliman CC, Paterson AJ, Dickey WO et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 37, 719-726 (1997).
17. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 105, 2266-2273 (2005). (Pubitemid 40387018)
18. Hall R, Stafford-Smith M, Rocker G. The systemic infammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth. Analg. 85, 766-782 (1997). (Pubitemid 27418878)
19. Silliman CC, Johnson CA, Clay KL, Thurman GW, Ambruso DR. Compounds biologically similar to platelet activating factor are present in stored blood components. Lipids 28, 415-418 (1993).
20. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br. J. Haematol. 136, 788-799 (2007). (Pubitemid 46348408)
21. Marik PE, Corwin HL. Acute lung injury following blood transfusion: expanding the defnition. Crit. Care Med. 36, 3080-3084 (2008).
22. Jutzi M, Levy G, Taleghani B. Swiss haemovigilance data and implementation of measures for the prevention of transfusion associated acute lung injury (TRALI). Transfus. Med. Hemother. 35, 98-101 (2008). (Pubitemid 351555900)
23. Eder AF, Herron Jr RM, Strupp A et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006-2008). Transfusion DOI: 10.1111/j. 1537-2995.2010.02652.x (2010) (Epub ahead of print).
24. Palf M, Berg S, Ernerudh J et al. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 41, 317-322 (2001). (Pubitemid 32238527)
25. Popovsky MA, Davenport RD. Transfusion-related acute lung injury: femme fatale? Transfusion 41, 312-315 (2001). (Pubitemid 32238525)
26. Welsby IJ, Troughton M, Phillips-Bute B et al. The relationship of plasma transfusion from female and male donors with outcome after cardiac surgery. J. Thorac. Cardiovasc. Surg. DOI:10.1016/j.jtcvs.2009.12.035 (2010) (Epub ahead of print).
27. Koch C, Li L, Figueroa P, Mihaljevic T, Svensson L, Blackstone EH. Transfusion and pulmonary morbidity after cardiac surgery. Ann. Thorac. Surg. 88, 1410-1418 (2009).
28. Wright SE, Snowden CP, Athey SC et al. Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasma. Crit. Care Med. 36, 1796-1802 (2008).
29. Khan H, Belsher J, Yilmaz M et al. Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest 131, 1308-1314 (2007). (Pubitemid 46762333)
30. Gajic O, Rana R, Winters JL et al Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am. J. Respir. Crit. Care Med. 176, 886-891 (2007). (Pubitemid 350097078)
31. Gajic O, Yilmaz M, Iscimen R et al Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit. Care Med. 35, 1645-1648 (2007). (Pubitemid 46985863)
32. Tynell E, Andersson TM, Norda R et al Should plasma from female donors be avoided? A population-based cohort study of plasma recipients in Sweden from 1990 through 2002. Transfusion 50(6), 1249-1256 (2010).
33. Middelburg RA, van Stein D, Zupanska B et al. Female donors and transfusion-related acute lung injury. Transfusion DOI: 10.1111/j. 1537-2995.2010.02715.x (2010) (Epub ahead of print).
34. Hillyer CD, Blumberg N, Glynn SA, Ness PM: Transfusion recipient epidemiology and outcomes research: possibilities for the future. Transfusion 48, 1530-1537 (2008).